US$ 29.44
glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Glucagon-Like Peptide-1 Receptor Agonist Use
Description
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6

[cited 2025 Feb 1]
Clinical relevance of antiexenatide antibodies: safety, efficacy and crossreactivity with longterm treatment

Moreover, durable weight management remains challenging

A GLP-1 analog, ROSE-010, was tested in IBS patients for pain relief, effectively increasing intestinal muscle movement [111]
